Suppr超能文献

在两名人类T细胞白血病/淋巴瘤病毒(HTLV)阳性淋巴瘤患者的循环免疫复合物中病毒抗原p24的证实。

Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukaemia/lymphoma virus (HTLV) positive lymphoma.

作者信息

Schüpbach J, Kalyanaraman V S, Sarngadharan M G, Bunn P A, Blayney D W, Gallo R C

出版信息

Lancet. 1984 Feb 11;1(8372):302-5. doi: 10.1016/s0140-6736(84)90358-1.

Abstract

Circulating immune complexes from two patients with human T-cell leukaemia/lymphoma virus (HTLV)-related lymphoma were shown to contain the major internal antigen of the virus, p24. The amount of complex-bound p24 in sequential serum samples correlated roughly with tumour cell mass. Small amounts of complex-bound p24 were detected in samples before a relapse became clinically manifest. Measurement of complex-bound p24 in patients with HTLV-associated lymphomas and leukaemias might thus be helpful in management of malignancies and offer the possibility of detecting imminent relapse and preventing it by intensification of treatment.

摘要

来自两名患有人T细胞白血病/淋巴瘤病毒(HTLV)相关淋巴瘤患者的循环免疫复合物被证明含有该病毒的主要内部抗原p24。连续血清样本中与复合物结合的p24量大致与肿瘤细胞量相关。在复发临床表现出现之前的样本中检测到少量与复合物结合的p24。因此,测量HTLV相关淋巴瘤和白血病患者中与复合物结合的p24可能有助于恶性肿瘤的管理,并提供检测即将复发并通过强化治疗预防复发的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验